Clinical Trial Update: Effects of Dapagliflozin on Central Hemodynamics and Urine Albumin Excretion in Patients With Type 2 Diabetes. [Phase 4]

View source ↗

Summary

Phase 4 trial update on dapagliflozin assessing effects on central hemodynamics and urine albumin excretion in type 2 diabetes patients; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Hellenic Society for Medical Education | Conditions: Diabetes Mellitus | Phase 4 | Status: TERMINATED